| References |
(2015) World Drug Report, , http://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf, (United Nations publication, Sales E.15.XI.6), 96; Shevyrin, V., Morzherin, Y., Cannabinoids: structures, effects, and classification (2015) Russ. Chem. Bull., Int. Ed., 64 (6), p. 1249; Habrdova, V., Peters, F.T., Theobald, D.S., Maurer, H.H., Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry (2005) J. Mass Spectrom., 40, p. 785; Shulgin, A., Shulgin, A., (1991) PIHKAL: A Chemical Love Story, , Transform Press, Berkeley, Californ; Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., Athanaselis, S., 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers (2015) Forensic Toxicol., 33, p. 1; Ewald, A.H., Fritschi, G., Bork, W.-R., Maurer, H.H., Designer drugs 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-bromomethamphetamine (MDOB): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques (2006) J. Mass Spectrom., 41, p. 487; Katagi, M., Tsuchihashi, H., Update on clandestine amphetamines and their analogues recently seen in Japan (2002) J. Health Sci., 48, p. 14; Maher, H.M., Awad, T., DeRuiter, J., Clark, C.R., GC–MS and GC–IRD studies on dimethoxyamphetamines (DMA): Regioisomers related to 2,5-DMA (2009) Forensic Sci. Int., 192, p. 115; Zaitsu, K., Katagi, M., Kamata, H., Kamata, T., Shima, N., Miki, A., Iwamura, T., Tsuchihashi, H., Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography–mass spectrometry (GC–MS) (2008) J. Mass Spectrom., 43, p. 528; Theobald, D.S., Fritschi, G., Maurer, H.H., Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography–mass spectrometry (2007) J. Chromatogr. B, 846, p. 374; Theobald, D.S., Pütz, M., Schneider, E., Maurer, H.H., New designer drug 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I): Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques (2006) J. Mass Spectrom., 41, p. 872; Theobald, D.S., Staack, R.F., Puetz, M., Maurer, H.H., New designer drug 2,5-dimethoxy-4-ethylthio-β-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry (2005) J. Mass Spectrom., 40, p. 1157; Zuba, D., Sekuła, K., Buczek, A., Identification and characterization of 2,5-dimethoxy-4-nitro-β-phenethylamine (2C-N) – a new member of 2C-series of designer drug (2012) Forensic Sci. Int., 222, p. 298; Theobald, D.S., Maurer, H.H., Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-β-phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques (2006) J. Mass Spectrom., 41, p. 1509; Wink, C.S.D., Meyer, M.R., Braun, T., Turcant, A., Maurer, H.H., Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MSn, and LC-high-resolution-MSn (2015) Anal. Bioanal. Chem., 407, p. 831; Takahashi, M., Nagashima, M., Suzuki, J., Seto, T., Yasuda, I., Yoshida, T., Analysis of phenethylamines and tryptamines in designer drugs using gas chromatography–mass spectrometry (2008) J. Health Sci., 54 (1), p. 89; Zuba, D., Sekuła, K., Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G) – a new designer drug (2013) Drug Test. Anal., 5, p. 549; Shulgin, A., Shulgin, A., (1997) THINKAL: The Continuation, , Transform Press, Berkel; Nichols, D.E., Sassano, M.F., Halberstadt, A.L., Klein, L.M., Brandt, S.D., Elliott, S.P., Fiedler, W.J., N‑benzyl-5-methoxytryptamines as potent serotonin 5‑HT2 receptor family agonists and comparison with a series of phenethylamine analogues (2015) ACS Chem. Neurosci., 6, p. 1165; Brandt, S.D., Elliott, S.P., Kavanagh, P.V., Dempster, N.M., Meyer, M.R., Maurer, H.H., Nichols, D.E., Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines (2015) Rapid Commun. Mass Spectrom., 29, p. 573; Rickli, A., Luethi, D., Reinisch, J., Buchy, D., Hoener, M.C., Liechti, M.E., Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) (2015) Neuropharmacol., 99, p. 546; Zuba, D., Sekuła, K., Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs (2013) Drug Test. Anal., 5, p. 634; Casale, J.F., Hays, P.A., Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues – part I (2012) Microgram Journal, 9 (2), p. 84; Zuba, D., Sekuła, K., Buczek, A., 25C-NBOMe – new potent hallucinogenic substance identified on the drug market (2013) Forensic Sci. Int., 227, p. 7; Hays, P.A., Casale, J.F., Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine – (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues – part II (2014) Microgram J., 11, p. 3; Poklis, J.L., Raso, S.A., Alford, K.N., Poklis, A., Peace, M.R., Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-methoxyphenyl) methyl]ethanamine derivatives on blotter paper (2015) J. Analyt. Toxicol., 39, p. 617; Lawn, W., Barratt, M., Williams, M., Horne, A., Winstock, A., The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample (2014) J. Psychopharmacol., 28, p. 780; Heim, R., (2003) Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts (in German), , http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221, Free University, Berl; Caspar, A.T., Helfer, A.G., Michely, J.A., Auwärter, V., Brandt, S.D., Meyer, M.R., Maurer, H.H., Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS (2015) Anal. Bioanal. Chem., 407, p. 6697; Poklis, J.L., Devers, K.G., Arbefeville, E.F., Pearson, J.M., Houston, E., Poklis, A., Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death (2014) Forensic Sci. Int., 234; Poklis, J.L., Nanco, C.R., Troendle, M.M., Wolf, C.E., Poklis, A., Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication (2014) Drug Test. Analysis, 6, p. 764; Andreasen, M.F., Telving, R., Rosendal, I., Eg, M.B., Hasselstrøm, J.B., Andersen, L.V., A fatal poisoning involving 25C-NBOMe (2015) Forensic Sci. Int., 251; Sekuła, K., Zuba, D., Structural elucidation and identification of a new derivative of phenethylamine using quadrupole time-of-flight mass spectrometry (2013) Rapid Commun. Mass Spectrom., 27, p. 2081; Fantegrossi, W.E., Gray, B.W., Bailey, J.M., Smith, D.A., Hansen, M., Kristensen, J.L., Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl)ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice (2015) Psychopharmacol., 232, p. 1039; Uchiyama, N., Shimokawa, Y., Matsuda, S., Kawamura, M., Kikura-Hanajiri, R., Goda, Y., Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products (2014) Forensic Toxicol., 32, p. 105; Westphal, F., Girreser, U., Waldmüller, D., Analytical characterization of four new orthomethoxybenzylated amphetamine-type designer drugs (2015) Drug Test. Analysis, , (Published online 26 NOV 2015; Boumrah, Y., Humbert, L., Phanithavong, M., Khimeche, K., Dahmania, A., Allorgec, D., In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS (2016) Drug Test. Analysis, 8, p. 248; Taniguchi, M., Yamamoto, Y., Nishi, K., A technique combining trifluoroacetyl derivatization and gas chromatography–mass spectrometry to distinguish methamphetamine and its 4-substituted analogs (2010) J. Mass Spectrom., 45, p. 1473; Blaazer, A.R., Smid, P., Kruse, C.G., Structure–activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors (2008) Chem. Med. Chem., 3, p. 1299; Stolyarov, B.V., Savinov, I.M., Vitenberg, A.G., Kartsova, L.A., Zenkevich, I.G., Kalmanovsky, V.I., Kalambet, Y.A., (2002) Practical Gas and Liquid Chromatography, , St. Petersburg University, St. Petersburg, (in Russian; Carreras, D., Imaz, C., Navajas, R., Garcia, M.A., Rodriguez, C., Rodriguez, A.F., Cortes, R., Comparison of derivatization procedures for the determination of diuretics in urine by gas chromatography–mass spectrometry (1994) J. Chromatography A, 683, p. 195; Pine, S.H., Sanchez, B.L., The formic acid-formaldehyde methylation of amines (1971) J. Org. Chem., 36 (6), p. 829; Blau, K., Halket, J.M., (1993) Handbook of Derivatives for Chromatography, , John Wiley & Sons, Second Editi; Murray, A., Williams, D.L., (1958) Organic Syntheses with Isotopes. Part II: Organic Compounds Labeled with Isotopes of the Halogens, Hydrogen, Nitrogen, Oxygen, Phosphorus, and Sulfur, , Interscience Publishers, New York, Lond; Richter, W.J., Vetter, W., Evidence for aryl participation in mass spectrometric fragmentation processes (1969) Org. Mass Spectrom., 2, p. 781; Kingston, D.G.I., Bursey, J.T., Bursey, M.M., Intramolecular hydrogen transfer in mass spectra. II. The McLafferty rearrangement and related reactions (1974) Chem. Rev., 74 (2), p. 215; Bursey, J.T., Bursey, M.M., Kingston, D.G.I., Intramolecular hydrogen transfer in mass spectra. I. Rearrangements in aliphatic hydrocarbons and aromatic compounds (1973) Chem. Rev., 73 (3), p. 191; McLafferty, F.W., Tureček, F., (1993) Interpretation of Mass Spectra, , 4th, University Science Books, Sausalito, Californ; Florêncio, H., Heerma, W., Dijkstra, G., The mass spectra of dimethoxytoluenes (1977) Org. Mass Spectrom., 12 (5), p. 269; Karni, M., Mandelbaum, A., The ‘even-electron rule’ (1980) Org. Mass Spectrom., 15 (2), p. 53; Wang, H.-Y., Gao, Y., Zhang, F., Yu, C.-T., Xu, C., Guo, Y.-L., Mass spectrometric study of the gas-phase difluorocarbene expulsion of polyfluorophenyl cations via F-atom migration (2013) J. Am. Soc. Mass Spectrom., 24, p. 1919 |